Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022
Champions Oncology (CSBR) will announce its fourth quarter financial results for the period ending April 30, 2022, on July 21, 2022, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Champions Oncology (CSBR) will announce its fourth quarter financial results for the period ending April 30, 2022, on July 21, 2022, after market close. A conference call is scheduled for 4:30 P.M. EDT to discuss these results, with participation details provided for both domestic and international callers. Champions Oncology specializes in AI-driven drug discovery and offers various R&D services to biopharma organizations, enhancing research efficiency and effectiveness.
Details
News Market Reaction – CSBR
The recorded move for CSBR in the trading session of this news was +4.90%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
HACKENSACK, NJ / ACCESSWIRE / July 14, 2022 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, will report its financial and operational results for the fourth quarter ended April 30, 2022, on Thursday, July 21, 2022, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EDT (1:30 P.M. PDT). To join the call dial 888-506-0062 (Domestic) or 973-528-0011 (International) and enter the access code 908668. A replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering passcode: 46134, or by accessing the investors section of the company's website within 72 hours.
About Champions Oncology, Inc.
Champions Oncology is a technology-driven research organization that develops innovative therapeutics against cancer targets, offers groundbreaking research software as a service, and provides end-to-end R&D services to biopharma organizations. Champions Oncology is actively engaged in the transformation of drug discovery through a novel approach of pharmaco-pheno-multiomic integration. For more information, please visit www.ChampionsOncology.com.
SOURCE: Champions Oncology, Inc.
View source version on accesswire.com:
https://www.accesswire.com/708456/Champions-Oncology-to-Announce-Fourth-Quarter-Financial-Results-on-Thursday-July-21-2022
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.